Code |
Title |
–
|
Top Categories
|
3 |
Administration
|
3E |
Physiological Systems and Anatomical Regions
|
3E0
|
Introduction
Administration, Physiological Systems and Anatomical Regions, Introduction
|
3E05 |
Peripheral Artery
|
3E050 |
Open
|
3E0500 |
Antineoplastic
|
3E05002
|
High-dose Interleukin-2
Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach
|
3E05003
|
Low-dose Interleukin-2
Introduction of Low-dose Interleukin-2 into Peripheral Artery, Open Approach
|
3E05005
|
Other Antineoplastic
Introduction of Other Antineoplastic into Peripheral Artery, Open Approach
|
3E0500M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach
|
3E0500P
|
Clofarabine
Introduction of Clofarabine into Peripheral Artery, Open Approach
|
3E0501 |
Thrombolytic
|
3E05016
|
Recombinant Human-activated Protein C
Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Open
|
3E05017
|
Other Thrombolytic
Introduction of Other Thrombolytic into Peripheral Artery, Open Approach
|
3E0502 |
Anti-infective
|
3E05028
|
Oxazolidinones
Introduction of Oxazolidinones into Peripheral Artery, Open Approach
|
3E05029
|
Other Anti-infective
Introduction of Other Anti-infective into Peripheral Artery, Open Approach
|
3E0503 |
Anti-inflammatory
|
3E0503Z
|
No Qualifier
Introduction of Anti-inflammatory into Peripheral Artery, Open Approach
|
3E0504 |
Serum, Toxoid and Vaccine
|
3E0504Z
|
No Qualifier
Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Open Approach
|
3E0506 |
Nutritional Substance
|
3E0506Z
|
No Qualifier
Introduction of Nutritional Substance into Peripheral Artery, Open Approach
|
3E0507 |
Electrolytic and Water Balance Substance
|
3E0507Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Open Approach
|
3E050F |
Intracirculatory Anesthetic
|
3E050FZ
|
No Qualifier
Introduction of Intracirculatory Anesthetic into Peripheral Artery, Open Approach
|
3E050G |
Other Therapeutic Substance
|
3E050GC
|
Other Substance
Introduction of Other Therapeutic Substance into Peripheral Artery, Open Approach
|
3E050GN
|
Blood Brain Barrier Disruption
Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Open Approach
|
3E050H |
Radioactive Substance
|
3E050HZ
|
No Qualifier
Introduction of Radioactive Substance into Peripheral Artery, Open Approach
|
3E050K |
Other Diagnostic Substance
|
3E050KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Peripheral Artery, Open Approach
|
3E050N |
Analgesics, Hypnotics, Sedatives
|
3E050NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Open Approach
|
3E050P |
Platelet Inhibitor
|
3E050PZ
|
No Qualifier
Introduction of Platelet Inhibitor into Peripheral Artery, Open Approach
|
3E050R |
Antiarrhythmic
|
3E050RZ
|
No Qualifier
Introduction of Antiarrhythmic into Peripheral Artery, Open Approach
|
3E050T |
Destructive Agent
|
3E050TZ
|
No Qualifier
Introduction of Destructive Agent into Peripheral Artery, Open Approach
|
3E050V |
Hormone
|
3E050VG
|
Insulin
Introduction of Insulin into Peripheral Artery, Open Approach
|
3E050VH
|
Human B-type Natriuretic Peptide
Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Open Approach
|
3E050VJ
|
Other Hormone
Introduction of Other Hormone into Peripheral Artery, Open Approach
|
3E050W |
Immunotherapeutic
|
3E050WK
|
Immunostimulator
Introduction of Immunostimulator into Peripheral Artery, Open
|
3E050WL
|
Immunosuppressive
Introduction of Immunosuppressive into Peripheral Artery, Open
|
3E050X |
Vasopressor
|
3E050XZ
|
No Qualifier
Introduction of Vasopressor into Peripheral Artery, Open Approach
|